Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Humanized (from mouse) |
Target | CD40 |
Clinical data | |
Pregnancy cat. | ? |
Legal status | ? |
Identifiers | |
CAS number | 880486-59-9 |
ATC code | None |
UNII | UT59FF4T5X |
Chemical data | |
Formula | C6452H9964N1732O1998S42 |
Mol. mass | 145.1 kDa (for the peptide) |
(verify) |
(what is this?)
Dacetuzumab (also known as SGN-40 or huS2C6) is a humanized monoclonal antibody[1] being developed for the treatment of CD40-positive cancers like non-Hodgkin's lymphoma[2] and hematological malignancies.[3]
This drug was developed by Seattle Genetics, Inc.